MagnetTx Oncology Solutions Ltd is a Canadian startup founded in 2015, aiming to revolutionize cancer treatment with their innovative technology. The company's slogan, "Developing a world-leading technology that combines Linac with MRI to deliver radiotherapy to cancer patients," captures their mission succinctly. Specializing in the Health Care industry, their flagship product, the Aurora-RT™, showcases their dedication to improving cancer patient outcomes while minimizing adverse side effects. The recent Corporate Round investment on 12 September 2019 underscores investor confidence in the company's vision. This strategic financial backing aligns with MagnetTx Oncology Solutions' potential to disrupt the market with their cutting-edge approach. As the company continues to solidify its position in the market, the infusion of capital will likely accelerate its research and development efforts, furthering its mission to improve cancer treatment. Operating out of Canada, MagnetTx Oncology Solutions Ltd stands at the forefront of innovative cancer treatment technology, poised to make a significant impact in the health care landscape. With its pioneering approach and recent investment, the company is well-positioned to drive positive change within the industry and potentially redefine the standards of cancer therapy.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Corporate Round | Unknown | - | 12 Sep 2019 | |
Series A | $3.00M | - | 01 Oct 2018 | |
Pre Seed Round | $25.00M | - | 01 Jan 2011 |
No recent news or press coverage available for MagnetTx Oncology Solutions Ltd.